HOME >> BIOLOGY >> NEWS
Premier international meeting provides latest news and issues in blood disorders

(San Diego, Calif., December 5, 2003) More than 20,000 physicians and scientists from around the world will gather for the 45th Annual Meeting of the American Society of Hematology (ASH), the premier multidisciplinary event in blood disease research, which takes place December 6 9, 2003, at the San Diego Convention Center. Researchers and other experts will present the latest breakthrough findings in the field of hematology, covering topics ranging from leukemia and lymphoma to thrombosis and stem cells.

"The ASH annual meeting is the premier event for academic and practicing hematologists throughout the world, providing a unique forum for hematologists to learn about scientific and clinical advances in the area of hematology research," said Ronald Hoffman, M.D., President of the American Society of Hematology.

Hematology is a subspecialty of internal medicine involving the study of blood, which affects all organs and virtually every human function. Hematologists treat patients with a wide range of blood-related conditions, including hemophilia, sickle cell anemia, HIV-AIDS, leukemias and lymphomas, and blood clotting disorders.

The Plenary Policy Forum (scheduled for Sunday, December 7, from 12:15 p.m. to 1:15 p.m. PST), will address health insurance coverage issues in the United States, and will feature the Honorable John Kitzhaber, M.D., former governor of Oregon. The discussion will address the increasing number of uninsured, a national problem affecting practicing physicians and their patients. Immediately following is the Plenary Scientific Session (1:15 p.m. to 3:45 p.m. PST), during which investigators chosen by ASH will present state-of-the-art research in the field of hematology. Presented abstracts will report on advances related to lymphoma, deep vein thrombosis, pediatric acute lymphoblastic leukemia and gene expression profiling, and polycythemia vera.

The Presidential Symposium (schedu
'"/>

Contact: Aimee Frank
afrank@spectrumscience.com
202-955-6222
American Society of Hematology
5-Dec-2003


Page: 1 2 3

Related biology news :

1. Premier international cancer meeting
2. Joslin President awarded medal from international diabetes organization
3. Increasing international insect threat to stored food
4. Ecologist calls for creation of an international panel to assess human behavior
5. Cutting-edge cancer researchers sought for international recognition
6. AACR: The premier international meeting for developments in cancer research
7. Principal investigators named for international scholars in breast cancer research program
8. Rice bioengineer wins international design contest
9. University of Minnesota professors to speak at symposium on international trade
10. AAAS hosts Battle of the Brains to choose area student for international competition
11. HHMI international programs build science capacity in developing countries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for ... Approval of this IND allows Sentien to initiate a Phase 1/2 study with ...
(Date:8/12/2020)... ... 2020 , ... Mosio recently announced its newly updated text ... of all sizes. With a focus on tracking symptoms and monitoring outbreaks as ... Mosio helps public health departments automate communications and provide more personalized care and ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense ... to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver ... “It’s the only technology of its kind on the market and we were pleased ... the protective capacity of traditional cultured ingredients, creating a natural way to extend the ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to ... move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
(Date:7/7/2020)... ... 06, 2020 , ... Bio-IT World has announced the winners ... the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance ... highlighting outstanding examples of how technology innovations and strategic initiatives can be powerful ...
(Date:6/28/2020)... ... ... The Indoor Lab, a leading provider of sensor solutions for monitoring foot ... ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using Artificial Intelligence ... a health performance index system that scores all aspects of compliance similar to the ...
Breaking Biology Technology:
Cached News: